Edwards Lifesciences Corp · Brief

Next report

No upcoming report date.

Expected move

No implied move.

8 reportsHistory

1 of 8≥ implied

Oct 24 '24±9.8%▼−1.38%×0.14

Feb 11 '25±5.1%▲+6.92%×1.36

Apr 23 '25±9.1%▲+6.63%×0.73

Jul 24 '25±8.9%▲+5.54%×0.63

Oct 30 '25±6.6%▼−1.23%×0.19

Feb 10 '26±7.3%▲+2.96%×0.40

Q1 FY26±8.8%▲+5.56%×0.63

Q2 FY26±9.0%▼−1.42%×0.16

quarterimplied−10%0+10%realized×

Q2 FY26±9.0%▼−1.42%×0.16

Q1 FY26±8.8%▲+5.56%×0.63

Feb '26±7.3%▲+2.96%×0.40

Oct '25±6.6%▼−1.23%×0.19

Jul '25±8.9%▲+5.54%×0.63

Apr '25±9.1%▲+6.63%×0.73

2 older reports

Feb '25±5.1%▲+6.92%×1.36

Oct '24±9.8%▼−1.38%×0.14

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

—

EW report session

No linked exposure.

Oct 29impliedImplied move: ±8.6% into Nov 2 earnings (Oct 29 close).Source

Oct 15impliedImplied move: ±8.4% into Oct 29 earnings (Oct 15 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.